Adding Lynparza to Presurgical Chemo May Not Boost TNBC Outcomes
The addition of Lynparza to presurgical chemotherapy did not improve outcomes for patients with basal-like BRCA wild-type triple-negative breast cancer.
United Kingdom San Francisco United States Karen Pinilla Alba Department Of Oncology Trial Consortium
Source: curetoday.com